Filing Details
- Accession Number:
- 0001493152-22-016088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-07 16:15:57
- Reporting Period:
- 2022-06-06
- Accepted Time:
- 2022-06-07 16:15:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1861657 | Hillstream Biopharma Inc. | HILS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360968 | Randy Milby | C/O Hillstream Biopharma, Inc. 1200 Route 22 East, Suite 2000 Bridgewater NJ 08807 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-06 | 234 | $0.68 | 2,937,774 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 100 | $0.67 | 2,937,874 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 100 | $0.67 | 2,937,974 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 66 | $0.67 | 2,938,040 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-06 | 500 | $0.70 | 2,938,540 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |